TokenPost·
Aytu BioPharma Agrees to Rosemont Buyout at $2.70 Per Share

A wholly owned Rosemont subsidiary plans to make a cash offer for all of Aytu’s outstanding common shares.
Every crypto headline. One feed. Updated every minute.

A wholly owned Rosemont subsidiary plans to make a cash offer for all of Aytu’s outstanding common shares.